Navigation Links
Roper Industries Announces Record Third Quarter Results
Date:10/25/2007

c. and Subsidiaries

Condensed Consolidated Balance Sheets (unaudited)

(Amounts in thousands)

September 30, December 31,

ASSETS 2007 2006

CURRENT ASSETS:

Cash and cash equivalents $125,931 $69,478

Accounts receivable 364,751 324,514

Inventories 183,021 168,319

Deferred taxes 19,086 17,908

Other current assets 71,321 47,276

Total current assets 764,110 627,495

PROPERTY, PLANT AND EQUIPMENT, NET 105,528 107,003

OTHER ASSETS:

Goodwill 1,689,904 1,651,208

Other intangible assets, net 626,093 544,136

Deferred taxes 24,795 21,702

Other assets 41,638 43,815

Total other assets 2,382,430 2,260,861

TOTAL ASSETS $3,252,068 $2,995,359

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:

Accounts payable $106,555 $96,139

Accrued liabilities 182,924 184,148

Income taxes payable 24,957 5,896

Deferred taxes 1,466 1,555

Current portion of long-term debt 322,147 299,911

Total current liabilities 638,049 587,649

NONCURRENT LIABILITIES:

Long-term debt 656,198
'/>"/>

SOURCE Roper Industries, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Proper Diet Can Counter Macular Degeneration
2. FDA issues warning for Droperidol
3. Tetanus causing toxin has therapeutic properties
4. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
5. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
6. The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties
7. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
8. Fruits And Vegetables Have Arthritis Risk Reducing Property
9. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
10. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
11. Improperly Placed And Heavy Backpacks Lead To Back Pain In School Children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...testicular cancer who were treated with cisplatin-...ncluding neurological side effects and Raynaud-lik...emotherapy, according to a new study published onl...ncer Institute . , Marianne Brydy, M.D., of the ...tal, in Bergen, Norway, and colleagues conducted a...
(Date:11/25/2009)...d was too short to draw definite conclusions, expe...Day News) -- In diabetic patients with blocked cor...in outcomes at one year whether patients undergo b...h researchers report. , Bypass surgery has been... coronary artery disease. However, less invasive a...
(Date:11/25/2009)...y neurological symptoms, study finds , ,...cal side effects are among the potential problems ...who were treated with cisplatin-based chemotherapy...,409 Norwegian men treated for unilateral testicul... follow-up survey conducted from 1998 to 2002. ,...
(Date:11/25/2009)...ntShownforthe4thStraightYear ,, WASHINGTON,No...iance-Georgia(LCA-GA)issuedthe 4thAnnualReportCard...ingmadeagainstthislethaldiseaseinthestateofGeorgia...nationalorganizationdedicatedexclusivelytopatients...gcancer. ,, (Logo: http://www.newscom.com/cgi-b...
(Date:11/25/2009)...er the skin kill tumor cells, study finds , ...cer vaccine delivered in a fingernail-size implant...eports. , The method uses polymer disks, 8.5 mi...specific antigens and implanted under the skin to ...Harvard University scientists who developed the im...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...ll and should not deter people from having the sur...althDay News) -- People who donate corneas are giv...g along a serious infection to the recipients, a n... in the February issue of the Archives of Ophthal...
.... 12 PSI, a leading provider of child,support enf...d today the,signing of a contract with the Ohio De...tinue delivering new hire reporting services for t...xtensions., Key responsibilities under the contra...
...b. 12 /PRNewswire/ - Over 5 million people in Nort...ng cause of hospitalization and for,the first time...ents want,to know - "How long do I have doctor?", ...d and diagnosed with heart failure. Scientists fol...
...Pa., Feb. 12 Herley Industries,Inc. (Nasdaq: HRL...ident,John M. Kelley, passed away after a lengthy ...Herley Industries, Inc. in 1998 as Director of,Inv...Technologies, and Executive Vice President before ...
... Fla., Feb. 12 The Generic Pharmaceutical,Associa...bers of its newly,elected Executive Committee and ...and CEO of Teva North America, to serve as its Cha...p 20,pharmaceutical companies in the world and is ...
...e International Experts to Educate Americans about...INNEAPOLIS, Feb. 12 Select Comfort Corporation,(N...and creator of the SLEEP,NUMBER(R) bed, has hand-p...an enhance their lives through better sleep,and a ...
Other Medicine News:Health News:Corneal Transplants Can Carry Infection Risk 2Health News:Corneal Transplants Can Carry Infection Risk 3Health News:Ohio Selects Policy Studies Inc. (PSI) to Continue Operating Its New Hire Reporting Program 2Health News:Precious Time - 'Scientists discover how long heart failure patients can expect to live' 2Health News:Precious Time - 'Scientists discover how long heart failure patients can expect to live' 3Health News:Herley Industries Announces the Passing of Its Former President 2Health News:GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 3
(Date:11/25/2009)...irstCall/--AmericanScientificResourcesInc.(PinkShe...haveopenedaregionalmarketingandproductionmanagemen...urealocationabroad,providinganessentialgatewayfort...andsafetyproductsforchildrenandadultstobedistribut...ryinthestateofOhiowheretheywillalsobeabletodosubco...
(Date:11/25/2009)...5/PRNewswire/-- FromNovember16-18,Phonak,theleadin...dthesecondeditionoftheHearingCareforAdultsConferen...heconferencebroughttogetherleadingexpertsinagingan...nswhoworkeverydaywitholderpeoplewithhearinglossfor...researchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 1Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 3Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: